We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
-2.53%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$68.4M
AUM Growth
-$43.1M
(-39%)
Cap. Flow
-$41.1M
Cap. Flow
% of AUM
-60.1%
Top 10 Holdings %
Top 10 Hldgs %
2.86%
Holding
1,768
New
383
Increased
275
Reduced
163
Closed
946
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CoStar Group
CSGP
|
+$225K |
| 2 |
Delek US
DK
|
+$221K |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$215K |
| 4 |
PCH
PotlatchDeltic
PCH
|
+$201K |
| 5 |
HEES
H&E Equipment Services
HEES
|
+$200K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GXO Logistics
GXO
|
+$470K |
| 2 |
Unisys
UIS
|
+$454K |
| 3 |
Schrodinger
SDGR
|
+$428K |
| 4 |
Leggett & Platt
LEG
|
+$408K |
| 5 |
Sutro Biopharma
STRO
|
+$394K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.74% |
| 2 | Industrials | 14.9% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Healthcare | 14.06% |
| 5 | Technology | 13.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Ultragenyx Pharmaceutical
RARE
$2.64B
| $104K | 0.15% |
2,531
+2,257
| +824% | +$96.4K |
|
302
SI-BONE Inc
SIBN
$739M
| $104K | 0.15% |
8,038
-5,868
| -42% | -$83.8K |
|
303
Wabash National
WNC
$550M
| $104K | 0.15% |
4,750
+122
| +3% | +$2.87K |
|
304
Koppers
KOP
$972M
| $103K | 0.15% |
+2,793
| New | +$130K |
|
305
Kontoor Brands
KTB
$4.68B
| $103K | 0.15% |
1,551
+1,395
| +894% | +$91.2K |
|
306
Costamare
CMRE
$1.89B
| $102K | 0.15% |
6,229
+1,750
| +39% | +$23.9K |
|
307
TriNet
TNET
$2.84B
| $102K | 0.15% |
+1,023
| New | +$114K |
|
308
Surgery Partners
SGRY
$2.11B
| $102K | 0.15% |
4,298
-2,101
| -33% | -$53.9K |
|
309
Comfort Systems
FIX
$62.8B
| $102K | 0.15% |
336
+143
| +74% | +$45.5K |
|
310
Bloom Energy
BE
$57.9B
| $102K | 0.15% |
+8,326
| New | +$106K |
|
311
Grand Canyon Education
LOPE
$3.74B
| $102K | 0.15% |
727
-462
| -39% | -$63.7K |
|
312
Berkshire Hathaway Class B
BRK.B
$1.07T
| $102K | 0.15% |
250
+193
| +339% | +$78.9K |
|
313
Archer Daniels Midland
ADM
$41.7B
| $102K | 0.15% |
1,681
-579
| -26% | -$35.5K |
|
314
American International
AIG
$41.7B
| $101K | 0.15% |
+1,364
| New | +$104K |
|
|
AKRO
315
DELISTED
Akero Therapeutics
AKRO
| $101K | 0.15% |
+4,311
| New | +$92.2K |
|
316
Reliance Steel & Aluminium
RS
$20.6B
| $101K | 0.15% |
354
+298
| +532% | +$89.8K |
|
317
RxSight
RXST
$214M
| $101K | 0.15% |
1,675
+1,132
| +208% | +$64.7K |
|
318
Primerica
PRI
$9.75B
| $101K | 0.15% |
+426
| New | +$96.6K |
|
319
Merck
MRK
$324B
| $100K | 0.15% |
+811
| New | +$104K |
|
320
Regions Financial
RF
$26.3B
| $100K | 0.15% |
5,001
+3,748
| +299% | +$72.7K |
|
321
US Bancorp
USB
$99.6B
| $99.6K | 0.15% |
+2,508
| New | +$102K |
|
322
Vita Coco
COCO
$3.89B
| $98.8K | 0.14% |
3,548
+3,070
| +642% | +$81.4K |
|
323
Aviat Networks
AVNW
$262M
| $98.4K | 0.14% |
+3,430
| New | +$109K |
|
|
MPX
324
DELISTED
Marine Products Corp
MPX
| $98.3K | 0.14% |
+9,730
| New | +$105K |
|
|
ZEUS
325
DELISTED
Olympic Steel
ZEUS
| $97.9K | 0.14% |
2,184
+1,327
| +155% | +$75.9K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q2 2024 Portfolio in Review
As of Q2 2024, EntryPoint Capital held 1,768 positions worth $68.4M, down 39% from $112M the previous quarter. Its ten largest holdings account for 2.9% of the portfolio.
EntryPoint Capital withdrew a net $41.1M in Q2 2024, closing 946 positions and reducing 163 holdings. Its most notable exit was GXO Logistics, an estimated $470K position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 13% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, EntryPoint Capital opened a new position in CoStar Group worth $197K.
- EntryPoint Capital's largest Q2 2024 buy was CoStar Group: 2,657 shares worth $197K.
- EntryPoint Capital added most to Martin Marietta Materials in Q2 2024, an estimated $181K increase.
- EntryPoint Capital's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $327K.
- EntryPoint Capital fully exited GXO Logistics in Q2 2024, selling an estimated $470K.
- EntryPoint Capital's ten largest holdings make up 2.9% of its $68.4M portfolio in Q2 2024.
- EntryPoint Capital opened 383 new positions and closed 946 in Q2 2024.
- EntryPoint Capital's portfolio value fell 39% quarter-over-quarter to $68.4M.
Based on EntryPoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.